Montelukast role in childhood asthma.

Australian Doctor,  December, 2006  

• E-mail
• Print
• Link

By Gabrielle Babbington

A SHORT course of montelukast (Singulair) in children with virally triggered asthma can improve symptoms and reduce school absences and parental time off work, research suggests.

The study of 220 children with intermittent asthma triggered by URTIs found parent-initiated treatment with montelukast -- a specific leukotriene receptor antagonist -- resulted in a 28.5% reduction in asthma episodes requiring unscheduled visits to a GP, paediatrician or hospital compared with placebo.

Montelukast treatment, which is currently only indicated for chronic ...

Read the rest of this article with a Free Trial at HighBeam Research.